Predictive Oncology Inc.
POAI
$0.99
-$0.0094-0.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -81.97% | 76.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -81.97% | 76.92% | |||
| Cost of Revenue | -84.48% | 47.59% | |||
| Gross Profit | -79.69% | 115.73% | |||
| SG&A Expenses | -3.78% | -0.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.35% | 2.84% | |||
| Operating Income | -7.69% | 8.23% | |||
| Income Before Tax | -8.78% | 7.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.78% | 7.99% | |||
| Earnings from Discontinued Operations | -129.26% | 91.53% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.60% | 29.89% | |||
| EBIT | -7.69% | 8.23% | |||
| EBITDA | -8.20% | 8.34% | |||
| EPS Basic | -5.11% | 32.82% | |||
| Normalized Basic EPS | -1.58% | 11.88% | |||
| EPS Diluted | -5.23% | 32.82% | |||
| Normalized Diluted EPS | -1.58% | 11.88% | |||
| Average Basic Shares Outstanding | 7.14% | 4.37% | |||
| Average Diluted Shares Outstanding | 7.14% | 4.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||